Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,085 | 90,903 | 101,446 | 94,629 | 62,288 |
| Marketable Securities | N/A | 1,501 | 1,518 | 18,777 | 56,300 |
| Receivables | 7,802 | 7,522 | 697 | 727 | 692 |
| Other current assets | 2,334 | 1,468 | 1,163 | 1,704 | 2,774 |
| TOTAL | $91,221 | $101,394 | $104,824 | $115,837 | $122,054 |
| Non-Current Assets | |||||
| PPE Net | 5,695 | 6,560 | 8,080 | 9,262 | 10,464 |
| Investments And Advances | 3,608 | 3,792 | 3,792 | 4,059 | 9,108 |
| Other Non-Current Assets | 200 | 1,867 | 350 | 520 | 520 |
| TOTAL | $9,503 | $12,219 | $12,222 | $13,841 | $20,092 |
| Total Assets | $100,724 | $113,613 | $117,046 | $129,678 | $142,146 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,623 | 5,836 | 6,341 | 6,865 | 6,379 |
| Other current liabilities | 85 | 170 | 57 | 57 | 57 |
| TOTAL | $7,708 | $6,006 | $12,350 | $16,127 | $18,441 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 5,952 | 9,205 | 12,005 |
| Other Non-Current Liabilities | 230 | 0 | 197 | 214 | 242 |
| TOTAL | $230 | $N/A | $197 | $214 | $242 |
| Total Liabilities | $7,938 | $6,006 | $12,547 | $16,341 | $18,683 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,400 | 32,230 | 31,663 | 31,411 | 31,023 |
| Common Shares | 42 | 42 | 41 | 41 | 40 |
| Retained earnings | -347,913 | -329,330 | -328,691 | -315,677 | -300,506 |
| Other shareholders' equity | -33 | -48 | -37 | -44 | -760 |
| TOTAL | $92,786 | $107,607 | $104,499 | $113,337 | $123,463 |
| Total Liabilities And Equity | $100,724 | $113,613 | $117,046 | $129,678 | $142,146 |